198 related articles for article (PubMed ID: 25205100)
1. Definition of smad3 phosphorylation events that affect malignant and metastatic behaviors in breast cancer cells.
Bae E; Sato M; Kim RJ; Kwak MK; Naka K; Gim J; Kadota M; Tang B; Flanders KC; Kim TA; Leem SH; Park T; Liu F; Wakefield LM; Kim SJ; Ooshima A
Cancer Res; 2014 Nov; 74(21):6139-49. PubMed ID: 25205100
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation status at Smad3 linker region modulates transforming growth factor-β-induced epithelial-mesenchymal transition and cancer progression.
Ooshima A; Park J; Kim SJ
Cancer Sci; 2019 Feb; 110(2):481-488. PubMed ID: 30589983
[TBL] [Abstract][Full Text] [Related]
3. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
4. Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site.
Huang CC; Huang MS; Chung HJ; Chiu SY; Yadav P; Lin Y; Liu F; Matsuura I
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3664-3671. PubMed ID: 30251686
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
[TBL] [Abstract][Full Text] [Related]
6. TGF-β downstream of Smad3 and MAPK signaling antagonistically regulate the viability and partial epithelial-mesenchymal transition of liver progenitor cells.
Sun YM; Wu Y; Li GX; Liang HF; Yong TY; Li Z; Zhang B; Chen XP; Jin GN; Ding ZY
Aging (Albany NY); 2024 Apr; 16(7):6588-6612. PubMed ID: 38604156
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
[TBL] [Abstract][Full Text] [Related]
8. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
9. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
Liu S; Jin K; Hui Y; Fu J; Jie C; Feng S; Reisman D; Wang Q; Fan D; Sukumar S; Chen H
Cancer Res; 2015 Feb; 75(4):709-19. PubMed ID: 25542862
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis.
Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K
Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465
[TBL] [Abstract][Full Text] [Related]
11. SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.
Fenizia C; Bottino C; Corbetta S; Fittipaldi R; Floris P; Gaudenzi G; Carra S; Cotelli F; Vitale G; Caretti G
Nucleic Acids Res; 2019 Feb; 47(3):1278-1293. PubMed ID: 30544196
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
[TBL] [Abstract][Full Text] [Related]
13. Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells.
Bae E; Kim SJ; Hong S; Liu F; Ooshima A
Biochem Biophys Res Commun; 2012 Oct; 427(3):593-9. PubMed ID: 23022526
[TBL] [Abstract][Full Text] [Related]
14. Phospho-specific Smad3 signaling: impact on breast oncogenesis.
Tarasewicz E; Jeruss JS
Cell Cycle; 2012 Jul; 11(13):2443-51. PubMed ID: 22659843
[TBL] [Abstract][Full Text] [Related]
15. Bcl-3 regulates TGFβ signaling by stabilizing Smad3 during breast cancer pulmonary metastasis.
Chen X; Cao X; Sun X; Lei R; Chen P; Zhao Y; Jiang Y; Yin J; Chen R; Ye D; Wang Q; Liu Z; Liu S; Cheng C; Mao J; Hou Y; Wang M; Siebenlist U; Eugene Chin Y; Wang Y; Cao L; Hu G; Zhang X
Cell Death Dis; 2016 Dec; 7(12):e2508. PubMed ID: 27906182
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells.
Grandclement C; Pallandre JR; Valmary Degano S; Viel E; Bouard A; Balland J; Rémy-Martin JP; Simon B; Rouleau A; Boireau W; Klagsbrun M; Ferrand C; Borg C
PLoS One; 2011; 6(7):e20444. PubMed ID: 21747928
[TBL] [Abstract][Full Text] [Related]
17. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
[TBL] [Abstract][Full Text] [Related]
18. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
Jin Q; Gao G; Mulder KM
J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
[TBL] [Abstract][Full Text] [Related]
19. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract][Full Text] [Related]
20. c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3.
Velden JL; Alcorn JF; Guala AS; Badura EC; Janssen-Heininger YM
Am J Respir Cell Mol Biol; 2011 Apr; 44(4):571-81. PubMed ID: 20581097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
